Pulmonary fibrosis is the end stage of many diffuse parenchymal lung diseases. It is
characterised by excessive matrix formation leading to destruction of the normal lung architecture …

… , a disease of premature aging, develop pulmonary fibrosis provided the first clue that mutations
in age-related genes may predispose to pulmonary fibrosis (20, 32). This association led …

… The etiology of pulmonary fibrotic diseases is … pulmonary fibrotic conditions, idiopathic
pulmonary fibrosis (IPF), is still unclear. This review examines common mechanisms of pulmonary …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease characterized
by the aberrant accumulation of fibrotic tissue in the lungs parenchyma, associated with …

… pulmonary fibrosis. In this article, we reviewed the relationship between interleukins and
pulmonary fibrosis … -targeted treatment on experimental pulmonary fibrosis, clinical applications …

… Idiopathic pulmonary fibrosis (IPF… pathogenesis it is likely that complex relationships between
genetic predispositions, environmental exposures, and lung infections promote the fibrotic …

… , pathogenesis, and diagnosis of pulmonary fibrosis with an … with risk of developing pulmonary
fibrosis, and an improved … in the development of pulmonary fibrosis is rapidly evolving. …

… pathogenesis of IPF has not been elucidated, early concepts focused on lung injury leading
to a cycle of chronic alveolar inflammation eventuating in fibrosis … in the pathogenesis of IPF, …

… been associated with pathogenic mechanisms such as … pathogenesis, most described
genetic variations are neither necessary nor sufficient for the development of pulmonary fibrosis…

Despite improvements in the diagnostic approach to idiopathic pulmonary fibrosis (IPF) in
recent years, the pathogenesis remains poorly understood. IPF is a clinical, physiologic, …